BioSpace News Archive

InHealth Technologies, maker of Blom-Singer® voice restoration and ENT products and a business unit of Freudenberg Medical, announces the commercial launch of Blom-Singer® SpeakFree™ HME Hands Free Valve created for people who have undergone a total laryngectomy.

Ridgeback Biotherapeutics, a biotechnology company experienced in antiviral drug development including medicines to treat SARS-Cov-2 and Ebola, announces deployment of the Ridgeback Ebola Rapid Response team to the Democratic Republic of the Congo.

POXEL today provided a corporate update and announced its cash position and revenue for the third quarter and the nine months ended September 30, 2021.

NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today announced it will report financial results for the third quarter of 2021 after market close on Wednesday, November 10, 2021.

Neurona Therapeutics, a biotherapeutics company advancing restorative neural cell therapies for the treatment of chronic neurological disorders, today announced that it has appointed Brad Margus to its board of directors.

Obsidio, Inc. today announced the expansion of its clinical advisory board with the appointment of two new members - Jafar Golzarian , MD, and Marc Sapoval , MD, PhD.

Oncoinvent to Present Four Posters at the 34th Annual Congress of the European Association of Nuclear Medicine

OncoSec Medical Incorporated today announced that Chris Twitty , Ph.D., Chief Scientific Officer,

Benchmark Electronics, Inc. (NYSE: BHE) will announce its third quarter 2021 results on Wednesday, October 27, 2021, after the market closes.

Pfizer Inc. (NYSE:PFE) announced today that the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) for routine use to help protect adults against invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae (pneumococcus) serotypes in the vaccine.